Site-directed Mutagenesis of CC Chemokine Receptor 1 Reveals the Mechanism of Action of UCB 35625, a Small Molecule Chemokine Receptor Antagonist
Open Access
- 1 February 2005
- journal article
- Published by Elsevier
- Vol. 280 (6) , 4808-4816
- https://doi.org/10.1074/jbc.m412267200
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Molecular Mechanism of AMD3100 Antagonism in the CXCR4 ReceptorJournal of Biological Chemistry, 2004
- Molecular characterization of the chemokine receptor CXCR3: evidence for the involvement of distinct extracellular domains in a multi‐step model of ligand binding and receptor activationEuropean Journal of Immunology, 2003
- Constitutive Activation of CCR5 and CCR2 Induced by Conformational Changes in the Conserved TXP Motif in Transmembrane Helix 2Published by Elsevier ,2003
- The CC Chemokine Eotaxin (CCL11) Is a Partial Agonist of CC Chemokine Receptor 2bJournal of Biological Chemistry, 2001
- The TXP Motif in the Second Transmembrane Helix of CCR5Journal of Biological Chemistry, 2001
- A Small Molecule Antagonist of Chemokine Receptors CCR1 and CCR3Published by Elsevier ,2000
- Identification of the Binding Site for a Novel Class of CCR2b Chemokine Receptor AntagonistsPublished by Elsevier ,2000
- HIV-1 Entry and Macrophage Inflammatory Protein-1β-mediated Signaling Are Independent Functions of the Chemokine Receptor CCR5Published by Elsevier ,1997
- Comparative Protein Modelling by Satisfaction of Spatial RestraintsJournal of Molecular Biology, 1993
- CHARMM: A program for macromolecular energy, minimization, and dynamics calculationsJournal of Computational Chemistry, 1983